addiction-science-dementia-care-2019-scientifictracks

Page 20

Volume 2

DEMENTIA AND DEMENTIA CARE

ADVANCES IN ADDICTION SCIENCE AND MEDICINE

July 24-25, 2019 | Rome, Italy

International Conference on

World Congress on

Addiction Science 2019 & Dementia Care 2019

July 24-25, 2019

Journal of Clinical Psychiatry and Neuroscience

J Clin Psychiatr Neurosci, Volume 2

Interventions and attitudes among U.S. and international surgeons treating patients

with infective endocarditis from intravenous drug use

Julie M Aultman

, Michael Firstenberg

, Dianne McCallister

and

Emanuela Peshel

Northeast Ohio Medical University, USA

HealthONE, USA

he treatment of patients with Intravenous Drug Use (IVDU) has evolved to include a wide range of medications, psychiatric

rehabilitation, and surgical interventions, especially for life-threatening complications such as Infective Endocarditis (IE).

Such interventions remain at the discretion of physicians, particularly surgeons, whose treatment decisions are not merely

influenced by medical factors, but also social justice issues ranging from physician bias to bedside rationing. These social

justice issues become heightened when IVDU patients require repeat valve replacement surgeries for IE due to relapse or

continued drug use. Patients who receive a valve replacement and continue to abuse illicit drugs intravenously, often return

to their medical providers months to a few years later with a re-infection of their bio prosthetic valve; such patients require

additional surgeries which are at the center of many ethical discussions due to high mortality rates associated with continuous

chemical dependency after surgical interventions. The following presentation details our study findings collected from 220

U.S. and international surgeons, who are involved either medically or surgically with the care of their IVDU-IE patients, and

their identified practices, attitudes, and ethical perspectives surrounding repetitive heart valve transplantations. Furthermore, we

describe the importance of integrative addiction care for this patient population and propose guidelines and best practices for

preventing relapse and subsequent patient harm. Our proposed guidelines and best practices are informed by comprehensive care

programs, interprofessional health care teams, and administrative support.

Biography

Julie MAultman, PhD, is a clinical ethicist and Professor of Family and Community Medicine, College of Medicine, NEOMED, where she

teaches and researches a variety of topics in bioethics and medical humanities and serves four clinical institutions as a clinical ethics

consultant. She is the Director for the Medical Ethics and Humanities Program, College of Graduate Studies. She holds leadership

positions within and external to NEOMED, including Chair of the IRB, Diversity Council, and Council on Academic Performance and

Professionalism for the College of Graduate Studies. Her research interests extend to psychiatric ethics, healthcare justice, international

studies in healthcare systems and community based rehabilitation programs, and moral and professional development in medical

education. Recent reseach areas have focused on the ethics of heart valve replacements for patients struggling with addiction, as well

as, justice issues surrouding access of care for refugee and undocumented patients.